how is hers still selling compounded semaglutide Hims & says its weight-loss business can grow as US market changes Hims & Hers to Stop

A comprehensive review on weight gain following discontinuation of glucagon-like peptide-1 receptor agonists for obesity

Ongoing support matters

doi: 10.1016/S2213-8587(23)00356-X 81 ApovianCMMcDonnellME

This medication is sold in a few forms: Ozempic (injectable): approved in2017for lowering blood sugar levels in adults with type 2 diabetes, as well as reducing the risk of heart attack, stroke, or death in those with type 2 diabetes and heart disease Rybelsus (tablet): approved in2019as the first and only GLP-1 analog in pill form and indicated to improve blood sugar regulation in adults with type 2 diabetes Wegovy (injectable): approved in2021for weight management Use of Rybelsus and Ozempic for weight loss is considered However, to maintain the weight loss benefits of semaglutide, people need to continue taking it